Source:http://linkedlifedata.com/resource/pubmed/id/11986236
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2002-5-2
|
pubmed:abstractText |
The t(10;11)(p12;q23) chromosomal translocation in human acute myeloid leukemia results in the fusion of the MLL and AF10 genes. The latter codes for a novel leucine zipper protein, one of many MLL fusion partners of unknown function. In this report, we demonstrate that retroviral-mediated transduction of an MLL-AF10 complementary DNA into primary murine myeloid progenitors enhanced their clonogenic potential in serial replating assays and led to their efficient immortalization at a primitive stage of myeloid differentiation. Furthermore, MLL-AF10-transduced cells rapidly induced acute myeloid leukemia in syngeneic or severe combined immunodeficiency recipient mice. Structure/function analysis showed that a highly conserved 82-amino acid portion of AF10, comprising 2 adjacent alpha-helical domains, was sufficient for immortalizing activity when fused to MLL. Neither helical domain alone mediated immortalization, and deletion of the 29-amino acid leucine zipper within this region completely abrogated transforming activity. Similarly, the minimal oncogenic domain of AF10 exhibited transcriptional activation properties when fused to the MLL or GAL4 DNA-binding domains, while neither helical domain alone did. However, transcriptional activation per se was not sufficient because a second activation domain of AF10 was neither required nor competent for transformation. The requirement for alpha-helical transcriptional effector domains is similar to the oncogenic contributions of unrelated MLL partners ENL and ELL, suggesting a general mechanism of myeloid leukemogenesis by a subset of MLL fusion proteins, possibly through specific recruitment of the transcriptional machinery.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Mll protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Mllt10 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Myeloid-Lymphoid Leukemia Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Oncogene Proteins, Fusion,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0006-4971
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
99
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3780-5
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:11986236-Amino Acid Motifs,
pubmed-meshheading:11986236-Amino Acid Sequence,
pubmed-meshheading:11986236-Animals,
pubmed-meshheading:11986236-COS Cells,
pubmed-meshheading:11986236-Cell Line,
pubmed-meshheading:11986236-Cell Transformation, Neoplastic,
pubmed-meshheading:11986236-Cells, Cultured,
pubmed-meshheading:11986236-Conserved Sequence,
pubmed-meshheading:11986236-DNA-Binding Proteins,
pubmed-meshheading:11986236-Leucine Zippers,
pubmed-meshheading:11986236-Leukemia, Myeloid,
pubmed-meshheading:11986236-Mice,
pubmed-meshheading:11986236-Mice, Inbred C57BL,
pubmed-meshheading:11986236-Mice, SCID,
pubmed-meshheading:11986236-Molecular Sequence Data,
pubmed-meshheading:11986236-Myeloid Progenitor Cells,
pubmed-meshheading:11986236-Myeloid-Lymphoid Leukemia Protein,
pubmed-meshheading:11986236-Oncogene Proteins, Fusion,
pubmed-meshheading:11986236-Protein Structure, Tertiary,
pubmed-meshheading:11986236-Proto-Oncogenes,
pubmed-meshheading:11986236-Sequence Alignment,
pubmed-meshheading:11986236-Transcription Factors,
pubmed-meshheading:11986236-Transcriptional Activation,
pubmed-meshheading:11986236-Transduction, Genetic
|
pubmed:year |
2002
|
pubmed:articleTitle |
The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10.
|
pubmed:affiliation |
Department of Pathology, Stanford University School of Medicine, CA 94305, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|